Obewise 10 is a pharmaceutical formulation containing Obeticholic acid at a concentration of 10 mg per tablet. Obeticholic acid is a synthetic bile acid analog that plays a crucial role in the management of liver diseases, particularly primary biliary cholangitis (PBC). This medication works by activating the farnesoid X receptor (FXR), which regulates bile acid synthesis and transport, thereby improving liver function and reducing the progression of liver damage.
Obewise 10 is primarily indicated for the treatment of patients with PBC, a chronic autoimmune disease that leads to the progressive destruction of the bile ducts in the liver. By enhancing bile flow and reducing the accumulation of toxic bile acids, Obeticholic acid helps alleviate symptoms associated with liver dysfunction, such as fatigue, pruritus (itching), and jaundice. Additionally, it may improve liver histology and slow the progression of fibrosis in patients with advanced liver disease.
The administration of Obewise 10 is typically oral, and the dosage may vary based on the individual’s condition and response to treatment. It is essential for patients to follow their healthcare provider's instructions regarding dosage and duration of therapy. While Obewise 10 is generally well-tolerated, some patients may experience side effects, including abdominal pain, nausea, diarrhea, and elevated liver enzymes. Regular monitoring of liver function tests is recommended to ensure the safety and efficacy of the treatment.
For optimal storage, Obewise 10 should be kept in a cool, dry place, away from direct sunlight and moisture. It is important to store the medication in its original packaging and out of reach of children to prevent accidental ingestion.